Diagnostic accuracy of a noninvasive hepatic ultrasound score for non-alcoholic fatty liver disease (NAFLD) in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)

Carregando...
Imagem de Miniatura
Citações na Scopus
22
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOCIACAO PAULISTA MEDICINA
Citação
SAO PAULO MEDICAL JOURNAL, v.133, n.2, p.115-124, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
CONTEXT AND OBJECTIVE: Noninvasive strategies for evaluating non-alcoholic fatty liver disease (NAFLD) have been investigated over the last few decades. Our aim was to evaluate the diagnostic accuracy of a new hepatic ultrasound score for NAFLD in the ELSA-Brasil study. DESIGN AND SETTINGS: Diagnostic accuracy study conducted in the ELSA center, in the hospital of a public university. METHODS: Among the 15,105 participants of the ELSA study who were evaluated for NAFLD, 195 individuals were included in this sub-study. Hepatic ultrasound was performed (deep beam attenuation, hepatorenal index and anteroposterior diameter of the right hepatic lobe) and compared with the hepatic steatosis findings from 64-channel high-resolution computed tomography (CT). We also evaluated two clinical indices relating to NAFLD: the fatty liver index (FLI) and the hepatic steatosis index (HSI). RESULTS: Among the 195 participants, the NAFLD frequency was 34.4%. High body mass index, high waist circumference, diabetes and hypertriglyceridemia were associated with high hepatic attenuation and large anteroposterior diameter of the right hepatic lobe, but not with the hepatorenal index. The hepatic ultrasound score, based on hepatic attenuation and the anteroposterior diameter of the right hepatic lobe, presented the best performance for NAFLD screening at the cutoff point >= 1 point; sensitivity: 85.1%; specificity: 73.4%; accuracy: 79.3%; and area under the curve (AUC 0.85; 95% confidence interval, CI: 0.78-0.91)]. FLI and HSI presented lower performance (AUC 0.76; 95% CI: 0.69-0.83) than CT. CONCLUSION: The hepatic ultrasound score based on hepatic attenuation and the anteroposterior diameter of the right hepatic lobe has good reproducibility and accuracy for NAFLD screening.
Palavras-chave
Liver disease, Epidemiology, Diagnostic techniques and procedures, Ultrasonography, Tomography, x-ray computed
Referências
  1. ALPERN MB, 1986, RADIOLOGY, V158, P45
  2. Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294
  3. Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33
  4. Borges VFDE, 2013, J CLIN ULTRASOUND, V41, P18, DOI 10.1002/jcu.21994
  5. Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466
  6. BYDDER GM, 1981, CT-J COMPUT TOMOGR, V5, P33
  7. Chiloiro M, 2008, CURR PHARM DESIGN, V14, P2693, DOI 10.2174/138161208786264197
  8. Chiloiro M, 2013, METAB SYNDR RELAT D, V11, P349, DOI 10.1089/met.2012.0169
  9. Cumberledge J, 2014, AM J GASTROENTEROL, V109, P1415, DOI 10.1038/ajg.2014.265
  10. Fedeli LG, 2013, REV SAUDE PUBL, V47, P63, DOI 10.1590/S0034-8910.2013047003807
  11. Fitzpatrick E, 2014, WORLD J GASTROENTERO, V20, P10851, DOI 10.3748/wjg.v20.i31.10851
  12. Fontana RJ, 2002, HEPATOLOGY, V36, pS57, DOI 10.1053/jhep.2002.36800
  13. Foster MC, 2011, HYPERTENSION, V58, P784, DOI 10.1161/HYPERTENSIONAHA.111.175315
  14. Gaitini D, 2004, ULTRASOUND MED BIOL, V30, P1321, DOI 10.1016/j.ultrasmedbio.2004.08.001
  15. Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579
  16. Hammerstingl RM, 2005, EUR RADIOL, V15, pE78, DOI 10.1007/s10406-005-0169-7
  17. Haring R, 2009, HEPATOLOGY, V50, P1403, DOI 10.1002/hep.23135
  18. Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452
  19. Lee JH, 2010, DIGEST LIVER DIS, V42, P503, DOI 10.1016/j.dld.2009.08.002
  20. Lee SS, 2010, J HEPATOL, V52, P579, DOI 10.1016/j.jhep.2010.01.008
  21. Lee SW, 2007, RADIOLOGY, V244, P479, DOI 10.1148/radiol.2442061177
  22. Limanond P, 2004, RADIOLOGY, V230, P276, DOI 10.1148/radiol.2301021176
  23. Lotufo PA, 2013, REV SAUDE PUBL, V47, P3
  24. Lu ZF, 1999, ULTRASOUND MED BIOL, V25, P1047, DOI 10.1016/S0301-5629(99)00055-1
  25. Lupsor Monica, 2005, Rom J Gastroenterol, V14, P419
  26. Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5
  27. Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161
  28. Marshall RH, 2012, AM J ROENTGENOL, V199, P997, DOI 10.2214/AJR.11.6677
  29. Matsuoka M, 2008, THESIS U SAO PAULO S
  30. Matsuoka Marcia Wang, 2011, Radiol Bras, V44, P141, DOI 10.1590/S0100-39842011000300004
  31. Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623
  32. NEEDLEMAN L, 1986, AM J ROENTGENOL, V146, P1011
  33. Perez NE, 2007, J CLIN GASTROENTEROL, V41, P624, DOI 10.1097/01.mcg.0000225680.45088.01
  34. ROFSKY NM, 1995, SEMIN ULTRASOUND CT, V16, P16, DOI 10.1016/0887-2171(95)90012-8
  35. Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354
  36. Sanyal A. J., 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572
  37. SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13
  38. Schmidt MI, 2014, INT J EPIDEMIOL
  39. Speliotes EK, 2010, HEPATOLOGY, V51, P1979, DOI 10.1002/hep.23593
  40. Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063
  41. Targher G, 2007, DIABETES CARE, V30, P2119, DOI 10.2337/dc07-0349
  42. Villanova N, 2005, HEPATOLOGY, V42, P473, DOI 10.1002/hep.20781
  43. von Volkmann HL, 2013, MED ULTRASON, V15, P16
  44. Webb M, 2009, AM J ROENTGENOL, V192, P909, DOI 10.2214/AJR.07.4016
  45. Wieckowska A, 2008, SEMIN LIVER DIS, V28, P386, DOI 10.1055/s-0028-1091983
  46. Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038
  47. YAJIMA Y, 1982, TOHOKU J EXP MED, V136, P337, DOI 10.1620/tjem.136.337
  48. Zelber-Sagi S, 2013, WORLD J GASTROENTERO, V19, P57, DOI 10.3748/wjg.v19.i1.57